US 11872200
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
granted A61KA61K31/197A61K31/4465
Quick answer
US patent 11872200 (GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes) held by The Regents of the University of California expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/197, A61K31/4465, A61K38/2013, A61K39/0008